TL;DR: KF 18280 (CAS 139339-11-0) is a chemical compound with molecular formula C22H16N4O and molecular weight 352.13242 g/mol, supplied by CoreyChem (Career Henan Chemical Co., Ltd.) with ISO-certified quality and global shipping.
3-benzyl-5-phenylimidazo[4,5-c][1,8]naphthyridin-4-one
Also Known As: KF 18280, 3,5-Dihydro-5-phenyl-3-(phenylmethyl)-4H-imidazo(4,5-c)(1,8)naphthyridin-4-one, 4H-Imidazo(4,5-c)(1,8)naphthyridin-4-one, 3,5-dihydro-5-phenyl-3-(phenylmethyl)-, 3-benzyl-5-phenylimidazo[4,5-c][1,8]naphthyridin-4-one, 3-benzyl-5-phenyl-3H,4H,5H-imidazo[4,5-c]1,8-naphthyridin-4-one
| Molecular Formula | C22H16N4O |
| Molecular Weight | 352.13242 g/mol |
| XLogP | 3.5 |
| Topological Polar Surface Area (TPSA) | 51.0 Ų |
| Hydrogen Bond Donors | 0 |
| Hydrogen Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Exact Mass | 352.13242 Da |
| Heavy Atoms | 27 |
| Complexity | 528.0 |
| SMILES | C1=CC=C(C=C1)CN2C=NC3=C2C(=O)N(C4=C3C=CC=N4)C5=CC=CC=C5 |
| InChIKey | HNQGGXAGBKEMKM-UHFFFAOYSA-N |
The XLogP value of 3.5 indicates that KF 18280 is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 51.0 Ų, KF 18280 exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, KF 18280 has 0 hydrogen bond donor(s) and 3 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
The CAS number of KF 18280 is 139339-11-0.
The molecular formula of KF 18280 is C22H16N4O.
The molecular weight of KF 18280 is 352.13242 g/mol.
You can request a quote for KF 18280 directly from CoreyChem. Contact us or email [email protected] for pricing and availability.
Yes, CoreyChem provides custom synthesis services for KF 18280 and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.
Request a quote for CAS 139339-11-0. Our professional technical team will respond with pricing and lead time.